European Journal of Cancer
Volume 43, Issue 16 , Pages 2351-2358, November 2007

A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer – GABG-IV B-93☆

  • Manfred Kaufmann

      Affiliations

    • Universitäts-Frauenklinik, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany
    • Corresponding Author InformationCorresponding author: Tel.: +49 69 63 01 51 15; fax: +49 69 63 01 63 17.
    • ,
  • Erika Graf

      Affiliations

    • Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Freiburg 79098, Germany
    • ,
  • Walter Jonat

      Affiliations

    • Universitäts-Frauenklinik, Kiel 24103, Germany
    • ,
  • Wolfgang Eiermann

      Affiliations

    • Rot-Kreuz-Krankenhaus, München 80331, Germany
    • ,
  • Sabine Vescia

      Affiliations

    • City Hospital, Hanau 63450, Germany
    • ,
  • Matthias Geberth

      Affiliations

    • Onkologische Praxis, Mannheim 68159, Germany
    • ,
  • Bettina Conrad

      Affiliations

    • Senologisches Zentrum, Kassel 34117, Germany
    • ,
  • Günther Gademann

      Affiliations

    • Universitätsklinikum, Magdeburg 39104, Germany
    • ,
  • Ute-Susann Albert

      Affiliations

    • Universitäts-Frauenklinik, Marburg 35037, Germany
    • ,
  • Sibylle Loibl

      Affiliations

    • Universitäts-Frauenklinik, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany
    • German Adjuvant Breast Cancer Study Group (GABG), 60596 Frankfurt, Germany
    • ,
  • Gunter von Minckwitz

      Affiliations

    • Universitäts-Frauenklinik, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany
    • German Adjuvant Breast Cancer Study Group (GABG), 60596 Frankfurt, Germany
    • ,
  • Martin Schumacher

      Affiliations

    • Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Freiburg 79098, Germany
    • ,
  • for the German Adjuvant Breast Cancer Study Group (GABG)

      Affiliations

    • German Breast Group (GBG), Neu-Isenburg 63263, Germany

Received 27 April 2007; received in revised form 16 July 2007; accepted 7 August 2007. published online 26 September 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The results of this study have been presented in part at the meeting of the American Society of Clinical Oncology in New Orleans, 2004.

PII: S0959-8049(07)00644-2

doi:10.1016/j.ejca.2007.08.012

European Journal of Cancer
Volume 43, Issue 16 , Pages 2351-2358, November 2007

Article Tools

* Image Usage & Resolution